PLUS THERAPEUTICS, Inc. (PSTV) Dividend History

Company News

• Plus Therapeutics Secures Private Placement of Approximately $15 Million in Gross Proceeds

  Plus Therapeutics, a clinical-stage pharmaceutical company, announced the pricing of a $15.0 million private placement. The funds will be used to advance the company's central nervous system cancer therapies and meet key near-term milestones.

  GlobeNewswire Inc.
• Durect (DRRX) Reports Q4 Loss, Misses Revenue Estimates

  DURECT (DRRX) delivered earnings and revenue surprises of 25% and 1.19%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research

  Featured Companies: DRRX
• Insiders Buying Plus Therapeutics And 2 Other Stocks Under $2

  The Dow Jones closed lower by around 40 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Plus Therapeutics The Trade: Plus Therapeutics, Inc. (NASDAQ: PSTV) Director Robert Lenk acquired a total of 7,395 shares an average price of $1.61. To acquire these shares, it cost around $11,933. What’s Happening: Plus Therapeutics ...

  Benzinga

  Featured Companies: SCKT WGS
• Penny Stocks To Buy Now? 4 To Watch Before Next Week

  Are these penny stocks to watch on your list this week? The post Penny Stocks To Buy Now? 4 To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

  PennyStocks

  Featured Companies: CLSK SPCE
• FAANG 2.0: Say Hello To MATANA, And Developments In Apple’s New Frontier

  Investing.com

  Featured Companies: AAPL ALB CDZI CF CHD FCX GSAT META MKC MSFT MTEX NEGG NFLX NVDA OXY PACB RCL REGN RIOT SAVA SEDG TSLA WMB